1. Search Result
Search Result
Results for "

1025687-58-4

" in MedChemExpress (MCE) Product Catalog:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-13038
    Fostamatinib Disodium
    Maximum Cited Publications
    9 Publications Verification

    R788(Disodium)

    Syk FLT3 Inflammation/Immunology Cancer
    Fostamatinib Disodium (R788 Disodium) is the oral proagent of the active compound R406 . R406 is an orally available and competitive Syk/FLT3 inhibitor with a Ki of 30 nM and an IC50 of 41 nM . R406 also inhibits Lyn (IC50=63 nM) and Lck (IC50=37 nM) .
    Fostamatinib Disodium
  • HY-13038A
    Fostamatinib
    Maximum Cited Publications
    9 Publications Verification

    R788

    Syk FLT3 Inflammation/Immunology Cancer
    Fostamatinib (R788) is the oral proagent of the active compound R406 . R406 is an orally available and competitive Syk/FLT3 inhibitor with a Ki of 30 nM and an IC50 of 41 nM . R406 also inhibits Lyn (IC50=63 nM) and Lck (IC50=37 nM) .
    Fostamatinib
  • HY-13038B
    Fostamatinib disodium hexahydrate
    Maximum Cited Publications
    9 Publications Verification

    R788 disodium hexahydrate

    Syk FLT3 Inflammation/Immunology Cancer
    Fostamatinib (R788) disodium hexahydrate is the oral proagent of the active compound R406 . R406 is an orally available and competitive Syk/FLT3 inhibitor with a Ki of 30 nM and an IC50 of 41 nM . R406 also inhibits Lyn (IC50=63 nM) and Lck (IC50=37 nM) .
    Fostamatinib disodium hexahydrate